| Ms Laurie Hiroko Fukushima, PHARMD | |
|
55 Mauilani Pkwy, Wailuku, HI 96793-2416 | |
| (808) 243-6107 | |
| (808) 243-6568 |
| Full Name | Ms Laurie Hiroko Fukushima |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 55 Mauilani Pkwy, Wailuku, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093861478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH-2437 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Laurie Hiroko Fukushima, PHARMD Po Box 331162, Kahului, HI 96733-1162 Ph: (808) 243-6107 | Ms Laurie Hiroko Fukushima, PHARMD 55 Mauilani Pkwy, Wailuku, HI 96793-2416 Ph: (808) 243-6107 |
News Archive
The National Institute of Allergy and Infectious Disease of the National Institutes of Health awarded more than $2 million to a research team at the George Washington University School of Medicine and Health Sciences to facilitate a Zika vaccine trial in Brazil.
The National Autism Association joins with organizations worldwide in recognizing April as Autism Awareness month. With one in 110 children now diagnosed with autism, and autism mortality rates doubling that of the general population, NAA is once again calling upon legislators and government health agencies to declare autism a national health emergency.
The number of clawed frogs used worldwide in research could soon be a fraction of the current number, following new research at the University of Portsmouth.
Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST). This is the sixth clinical study of STA-9090, a potent, synthetic, small molecule Hsp90 inhibitor with a novel chemical structure.
› Verified 8 days ago
Dr. Barbara T Armstrong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Mauilani Pkwy, Wailuku, HI 96793 Phone: 808-243-6050 | |
Dr. Melissa Swoope, PHARM, D. RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Mauilani Pkwy, Wailuku, HI 96793 Phone: 808-243-6565 | |
Mr. Dean Royd Kobayashi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2180 Main St, Wailuku, HI 96793 Phone: 808-244-7252 Fax: 808-242-5837 | |
Chimene Marie Sienkiewicz, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Mauilani Pkwy, Wailuku, HI 96793 Phone: 808-243-6565 | |
Lauren Levine, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Kehalani Village Dr, Wailuku, HI 96793 Phone: 808-242-5606 | |
Dr. Brandi Lyn Hommel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 55 Mauilani Pkwy, Wailuku, HI 96793 Phone: 808-243-6560 Fax: 808-243-6586 |